Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04949464 · ClinicalTrials.gov registry record · NA
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
A NA study of HIV Infection and Tobacco-Related Carcinoma, sponsored by AIDS Malignancy Consortium.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 11
- Study locations
NCT04949464 is a NA study of HIV Infection and Tobacco-Related Carcinoma that is actively recruiting participants, run by AIDS Malignancy Consortium. The registered enrollment target is 100 participants, below the 241-participant average among 73 other HIV Infection trials with a reported enrollment target (59% lower). The trial reports 11 study locations across 9 states.
The verdict
NCT04949464, a NA study of HIV Infection and Tobacco-Related Carcinoma, is actively recruiting participants, sponsored by AIDS Malignancy Consortium.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 11
- Study locations
Study Summary
This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.
Conditions Studied
Interventions
- PROCEDURE Computed Tomography
- BEHAVIORAL Smoking Cessation Intervention
Study Locations (11)
New York
- Weill Cornell Medicine - Cornell Clinical Trials Unit - New York
- Mount Sinai Hospital - New York
- Montefiore Medical Center - The Bronx
California
- UC San Diego Moores Cancer Center - La Jolla
District of Columbia
- George Washington University - Washington D.C.
Florida
- Moffitt Cancer Center - Tampa
Missouri
- Washington University School of Medicine - St Louis
Ohio
- The Ohio State University James Cancer Hospital - Columbus
Pennsylvania
- Thomas Jefferson University - Philadelphia
Texas
- University of Texas M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-22 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04949464
The ClinicalTrials.gov registry entry for NCT04949464 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 73 other HIV Infection trials with a reported enrollment target (59% lower). The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infection appearing as the primary indexed condition, and to 2 interventions - of which Computed Tomography is the first listed.
NCT04949464 reports 11 study locations spanning 9 distinct geographic areas - top geographies include New York, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04949464 about?
NCT04949464 is a clinical study titled "Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study". This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.
What is the current status of trial NCT04949464?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-03-22. Estimated completion is 2027-03-31.
What conditions does trial NCT04949464 study?
This clinical trial studies the following conditions: HIV Infection, Tobacco-Related Carcinoma.
What interventions are being tested in trial NCT04949464?
The interventions under investigation include: Computed Tomography (PROCEDURE), Smoking Cessation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04949464?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04949464 being conducted?
This trial has 11 study locations across California, District of Columbia, Florida, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
RECRUITING · NA
-
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
RECRUITING · NA
-
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
Technology-based Training Tool for PHAT Life
COMPLETED · NA
-
Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.